Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Aspirin and clopidogrel resistance using the cone and plate(let) analyser in Indian patients with coronary artery disease.

Koshy SK, Salahuddin S, Karunakaran B, Nalakath SY, Bhaskaran J, Haridas PV, Mandalay A, Faizal A.

Heart Asia. 2014 Nov 7;6(1):159-62. doi: 10.1136/heartasia-2014-010568. eCollection 2014.

2.

Antiplatelet Effect of Sequential Administration of Cilostazol in Patients with Acetylsalycilic Acid Resistance.

Cakmak M, Demircelik B, Cetin M, Cetin Z, Isık S, Cıcekcıoglu H, Ulusoy FV, Eryonucu B.

Acta Cardiol Sin. 2016 May;32(3):321-7.

3.

Biochemical aspirin resistance in stroke patients - a cross-sectional single centre study.

Azmin S, Sahathevan R, Rabani R, Nafisah WY, Tan HJ, Raymond AA, Hamidon BB, Shamsul AS, Norlinah MI.

EXCLI J. 2013 Oct 29;12:907-15. eCollection 2013.

4.

Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study.

Ellero-Simatos S, Beitelshees AL, Lewis JP, Yerges-Armstrong LM, Georgiades A, Dane A, Harms AC, Strassburg K, Guled F, Hendriks MM, Horenstein RB, Shuldiner AR, Hankemeier T, Kaddurah-Daouk R; Pharmacometabolomics Research Network.

J Am Heart Assoc. 2015 Oct 26;4(10):e002203. doi: 10.1161/JAHA.115.002203.

5.

The inhibitory mechanism of crude saponin fraction from Korean Red Ginseng in collagen-induced platelet aggregation.

Jeon BR, Kim SJ, Hong SB, Park HJ, Cho JY, Rhee MH.

J Ginseng Res. 2015 Jul;39(3):279-85. doi: 10.1016/j.jgr.2015.02.001. Epub 2015 Feb 23.

6.

6(th) Asian PAD Workshop.

[No authors listed]

Ann Vasc Dis. 2015;8(2):135-43. doi: 10.3400/avd.pad.15-00001. No abstract available.

7.

Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy.

Gremmel T, Koppensteiner R, Panzer S.

PLoS One. 2015 Jun 9;10(6):e0129666. doi: 10.1371/journal.pone.0129666. eCollection 2015.

8.

Antiplatelet resistance and the role of associated variables in stable patients treated with stenting.

Uzun F, Biyik I, Akturk IF, Erturk M, Yalcin AA, Surgit O, Oner E, Pusuroglu H, Birand A.

Postepy Kardiol Interwencyjnej. 2015;11(1):19-25. doi: 10.5114/pwki.2015.49180. Epub 2015 Mar 6.

9.

Overcoming aspirin resistance with loading clopidogrel earlier in elective percutaneous coronary intervention.

Ozcan OU, Tutar E, Candemir B, Ustun EE, Erol C.

Int J Angiol. 2015 Mar;24(1):19-24. doi: 10.1055/s-0034-1395981.

10.

Attending to links in the safety chain for drug-eluting stents.

Fitzgerald PJ, Leon MB.

Neth Heart J. 2006 Sep;14(9):285-286. No abstract available.

11.

Methodological issues and recommendations for systematic reviews of prognostic studies: an example from cardiovascular disease.

Dretzke J, Ensor J, Bayliss S, Hodgkinson J, Lordkipanidzé M, Riley RD, Fitzmaurice D, Moore D.

Syst Rev. 2014 Dec 3;3:140. doi: 10.1186/2046-4053-3-140. Review.

12.

Antiplatelet therapy for carotid artery stenting.

Enomoto Y, Yoshimura S.

Interv Neurol. 2013 Sep;1(3-4):151-63. doi: 10.1159/000351686. Review.

13.

Impact of aspirin and clopidogrel interruption on platelet function in patients undergoing major vascular surgery.

Le Manach Y, Kahn D, Bachelot-Loza C, Le Sache F, Smadja DM, Remones V, Loriot MA, Coriat P, Gaussem P.

PLoS One. 2014 Aug 20;9(8):e104491. doi: 10.1371/journal.pone.0104491. eCollection 2014.

14.

Recovery time of platelet function after aspirin withdrawal.

Lee J, Kim JK, Kim JH, Dunuu T, Park SH, Park SJ, Kang JY, Choi RK, Hyon MS.

Curr Ther Res Clin Exp. 2014 Mar 25;76:26-31. doi: 10.1016/j.curtheres.2014.02.002. eCollection 2014 Dec.

15.

Pharmacometabolomics reveals that serotonin is implicated in aspirin response variability.

Ellero-Simatos S, Lewis JP, Georgiades A, Yerges-Armstrong LM, Beitelshees AL, Horenstein RB, Dane A, Harms AC, Ramaker R, Vreeken RJ, Perry CG, Zhu H, Sànchez CL, Kuhn C, Ortel TL, Shuldiner AR, Hankemeier T, Kaddurah-Daouk R.

CPT Pharmacometrics Syst Pharmacol. 2014 Jul 16;3:e125. doi: 10.1038/psp.2014.22.

16.

Acetylsalicylic Acid resistance in patients with type 2 diabetes mellitus, prediabetes & non-diabetic coronary artery disease.

Cetin M, Kiziltunc E, Cetin ZG, Cicekcioglu H, Sahin M, Isik S, Kurtul A, Ornek E, Ulusoy FV.

Pak J Med Sci. 2014 May;30(3):539-44. doi: 10.12669/pjms.303.4773.

17.

Chinese herbal medicine for aspirin resistance: a systematic review of randomized controlled trials.

Liu AJ, Li HQ, Li JH, Wang YY, Chen D, Wang Y, Zheng GQ.

Evid Based Complement Alternat Med. 2014;2014:890950. doi: 10.1155/2014/890950. Epub 2014 Feb 20. Review.

18.

Antiplatelet Activity of Morus alba Leaves Extract, Mediated via Inhibiting Granule Secretion and Blocking the Phosphorylation of Extracellular-Signal-Regulated Kinase and Akt.

Kim DS, Ji HD, Rhee MH, Sung YY, Yang WK, Kim SH, Kim HK.

Evid Based Complement Alternat Med. 2014;2014:639548. doi: 10.1155/2014/639548. Epub 2014 Feb 19.

19.

Aspirin resistance and promoting blood circulation and removing blood stasis: current situation and prospectives.

Wang J, Xiong X, Feng B.

Evid Based Complement Alternat Med. 2014;2014:954863. doi: 10.1155/2014/954863. Epub 2014 Feb 18. Review.

20.
Items per page

Supplemental Content

Write to the Help Desk